Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|October 1, 2004
Selective gray matter damage in neuropsychiatric lupusS C A Steens, F Admiraal-Behloul, G P Th Bosma, et al.
Arthritis and Rheumatism|August 1, 2008
Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritisDanielle Cohen, Marije Koopmans, Idske C L Kremer Hovinga, et al.
Brain : a Journal of Neurology|March 13, 2016
Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolitesEce Ercan, Cesar Magro-Checa, Romain Valabregue, et al.
European Radiology|April 30, 2021
Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRIFrancesca Inglese, Ilse M J Kant, Rory C Monahan, et al.
Arthritis Care & Research|April 26, 2022
High Prevalence but Low Impact of Cognitive Dysfunction on Quality of Life in Patients With Lupus and Neuropsychiatric SymptomsRory C Monahan, Huub A M Middelkoop, Liesbeth J J Beaart-van de Voorde, et al.
Annals of the Rheumatic Diseases|July 10, 2026
Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosusLars C van Vliet, Annemarie L Dorjée, Martijn van der Heide, et al.
Lupus|December 12, 2018
Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohortC Magro-Checa, S Kumar, S Ramiro, et al.
Annals of the Rheumatic Diseases|May 22, 2003
A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosusS C A Steens, G P Th Bosma, R ten Cate, et al.
Clinical Rheumatology|September 30, 2016
Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remissionG Akdemir, I M Markusse, Y P M Goekoop-Ruiterman, et al.
Lupus|March 29, 2021
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activityRory C Monahan, Liesbeth Jj Beaart-van de Voorde, Jeroen Eikenboom, et al.
Pageof 10